Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 18 , ISSUE 7 ( July, 2014 ) > List of Articles

EDITORIAL

Colistin pharmacokinetics/pharmacodynamics and acute kidney injury: A difficult but reasonable marriage

Patrick M. Honore, Rita Jacobs, Elisabeth De Waele, Viola Van Gorp, Herbert D. Spapen

Citation Information : Honore PM, Jacobs R, Waele ED, Gorp VV, Spapen HD. Colistin pharmacokinetics/pharmacodynamics and acute kidney injury: A difficult but reasonable marriage. Indian J Crit Care Med 2014; 18 (7):415-416.

DOI: 10.4103/0972-5229.136065

License: CC BY-ND 3.0

Published Online: 01-07-2014

Copyright Statement:  Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Spapen H, Jacobs R, Van Gorp V, Troubleyn J, Honoré PM. Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 2011;1:14.
  2. Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria. Antimicrob Agents Chemother 2009;53:3430-6.
  3. Honore PM, Jacobs R, Joannes-Boyau O, Lochy S, Boer W, De Waele E, et al. CRRT-related strategies to avoid colistin toxicity: A clinically orientated review. Blood Purif 2014. [In press].
  4. Honore PM, Jacobs R, Lochy S, De Waele E, Van Gorp V, De Regt J, et al. Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: Key potential role of hemoadsorption elimination during continuous venovenous hemofiltration. Int J Nephrol Renovasc Dis 2013;6:107-11.
  5. Lee J, Han S, Jeon S, Hong T, Song W, Woo H, et al. Population pharmacokinetic analysis of colistin in burn patients. Antimicrob Agents Chemother 2013;57:2141-6.
  6. Honoré PM, Jacobs R, De Regt J, Van Gorp V, De Waele E, Spapen HD. Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients-Please, be adequate! Crit Care 2014;18:412.
  7. Dewan A, Shankat M. Evaluation of risk of nephrotoxicity with high dose, extended-interval colistin administration. Indian J Crit Care Med 2014;18:427-30.
  8. Honore PM, Jacobs R, Joannes-Boyau O, Boer W, De Waele E, Van Gorp V, et al. Continuous renal replacement therapy allows higher colistin dosing without increasing toxicity. J Transl Intern Med 2013;1:6-8.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.